1[1]de Mendonca Filho HT,Comes RV,de Almeida Campos LA,et al.Circulating levels of maemphage migration inhibitory faetor are associated witIl mild puhnonary dysfunction after cardiopulmonary bypass[J].Shock,2004,22 (6):533-537. 被引量：1
2[2]Giomardli P,ScoleRa S,Borrelli E,et al.Myocardial and lung injury after eardiopulmonary bypass:role of imerleukin (IL) lO[J].Ann Thorac Surg,2003,76 (1):117-123. 被引量：1
3[3]Rinder CS,RiMer HM,Smith MJ,et al.Amithrombin reduces monocyte and neutrophil CDl lb up regulation in addition to blocking phtdct activation during extracorporeal circulation[J].Transfusion,2006,46 (7):1130-1137. 被引量：1
4[4]Kovesi T,Szabo A,Royston D,et al.Correlation between palmonary gas exchange and basal and nitroglycerin (GTN) induced exhaled nitric oxide (eNO) in patients undergoing cardiac surgery[J].Vascul Pharmanol,2005,43 (6):434-440. 被引量：1
5[5]ScMensak C,Doenst T,Prcusser S,et al.Cardiopuhnonary bypass reduction of bronchial blood flow:a potential mechanism for lung injury in a neonatal pig model[J].J Thorac Cardiovase surg,2002,123 (6):1199-1205. 被引量：1
6[6]Suzuki T,Fukuda T,ho T,et al.Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injmy in in fants[J].Ann Thorac Surg,2000,69 (2):602-606. 被引量：1
7[7]Babik B,Asztalos T,Petak F,et al.changes in respiratory meehanies during cardiac surgery[J].Anesth AnaJg,2003,96 (5):1280-1287. 被引量：1
9[9]Sievers HH,Freund Kaas C,Eleftheriadis S,et al.Lung protection during total cardiopulmonary bypass by isolated lung perfusion:preliminary results of a novel perfusion strategy[J].Ann Thorac Surg,2002,74 (4):1167-1172. 被引量：1
10[10]de Vroege R,van Oeveren W,van Klarenbosch J,et al.The impact of heparin coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators[J].Anesth Analg,2004,98 (6):1586-1594. 被引量：1
二级参考文献23
1Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology,2002, 97: 215-252. 被引量：1
2Tsuchiya M, Asada A, Maeda K, et al. Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med, 2001,163: 26-31. 被引量：1
3Inada T, Taniuchi S, Shingu K, et al. Propofol depressed neutrophil hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg, 2001,92: 437-441. 被引量：1
4Cruz JP, SedeAo G, Carmona JA, et al. The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg, 1998, 87: 1141-1146. 被引量：1
5Kwak SH, Choi J, Park JT. Effects of propofol on endotoxin-induced acute lung injury in rabbit. J Korean Med Sci, 2004, 19: 55-61. 被引量：1
6Gao J, Zeng BX, Zhou LJ, et al. Protective effects of early treatment with propofol on endotoxininduced acute lung injury in rats. Br J Anaesth, 2004, 92: 277-279. 被引量：1
9Ballaux PK, Gourlay T, Ratnatunga CP, et al. A literature review of cardiopulmonary bypass models for rats. Perfusion, 1999,14: 411-417. 被引量：1
10Hamamoto M, Suga M, Nakatani T, et al. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model. Eur J Cardiothorac Surg, 2004, 25: 833-838. 被引量：1
8Ask A, Holt D, Smith L. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass. J Extra Corpot Technol ,2006,38 (!) :27 -32 被引量：1
9Huang H,Yao T, Wang W, al et. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg,2003,76( 1 ) : 136 - 140 被引量：1
10Lou S, Liu YL, Liu JP. Effects of zero-balanced ultrafihration on procalcitonin and respiratory function after cardiopulmonary bypass. Perfusion ,2007,22 (5) : 339 - 343 被引量：1
